J Obes Metab Syndr.
2017 Sep;26(3):155-160. 10.7570/jomes.2017.26.3.155.
GLP-1 Based Combination Therapy for Obesity and Diabetes
- Affiliations
-
- 1Functional Neuroanatomy of Metabolism Regulation Laboratory, Department of Anatomy, Seoul National University College of Medicine, Seoul, Korea. hjchoi@snu.ac.kr
- 2Department of Anatomy and Cell Biology, Seoul National University College of Medicine, Seoul, Korea.
- 3BK²¹Plus Biomedical Science Project Team, Seoul, Korea.
- 4Neuroscience Research Institute, Seoul National University College of Medicine, Seoul, Korea.
- 5Wide River Institute of Immunology, Seoul National University, Hongcheon, Korea.
- KMID: 2392940
- DOI: http://doi.org/10.7570/jomes.2017.26.3.155
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical Application of Glucagon-Like Peptide-1 Receptor Agonists
- Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
- 2023 Clinical Practice Guidelines for Diabetes: Recommendations for Pharmacological Treatment of Type 2 Diabetes
- The Global Shortage of Glucagon-Like Peptide-1 Receptor Agonists
- The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor - An Update
